Insider · CIK 0001300111
Joseph C Sardano
Files at SRTS (Sensus Healthcare, Inc.). First filing Nov 19, 2025, latest Aug 24, 2026.
In brief
Joseph C Sardano files SEC Form 4 as CEO and director at SRTS (Sensus Healthcare, Inc.). Since Nov 19, 2025, Joseph C Sardano has reported 2 open-market buys worth $161k and 0 open-market sells worth $0, the latest filed on Aug 24, 2026.
A track record needs three past buys with six months of prices behind them; Joseph C Sardano has 1, so none is measured yet.
The newest scored trade: bought $60k of SRTS on Aug 20, 2026, filed Aug 24, 2026, scored 48 (moderate). In the last 12 months: 2 buys worth $161k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SRTS: Sensus Healthcare, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Sensus Healthcare, Inc. | $60k 20,000 shares | +2% | +20% from low-39% from high | |
| 50Moderate | Sensus Healthcare, Inc. | $101k 25,000 shares | +2% | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stock | +20,000 | $3.02 | $60k | 1,220,293 | Aug 24, 2026 |
| Nov 18, 2025 | SRTS Sensus Healthcare, Inc. | POpen-market purchase Common Stock | +25,000 | $4.03 | $101k | 1,200,293 | Nov 19, 2025 |
Questions about Joseph C Sardano
Answered from the filings on this page, as of the latest one.
Is Joseph C Sardano buying or selling?
In the last 12 months Joseph C Sardano reported 2 open-market buys worth $161k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $60k of SRTS on Aug 20, 2026. Grants, option exercises and tax withholding are not counted.
How did Joseph C Sardano's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph C Sardano has 1.
Where does Joseph C Sardano file Form 4?
Joseph C Sardano has filed Form 4 at SRTS (Sensus Healthcare, Inc.) as CHIEF EXECUTIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.